LD-2 disclosure · 1st Quarter - Report
LUNDBECK PHARMACEUTICALS LLC
Client
- Description
- Specialty and Central Nervous System Bio-pharmaceutical manufacturing.
- Location
- Illinois · United States of America
Registrant
- Description
- Government affairs.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act.
LobbyistsSHANNON FINLEY · LUKE HATZIS · ANN JABLON · MARTHA KENDRICK · JEFFREY CARROLL · NICK BOUKNIGHT · MICHELLE MATHY · JOHN MARTIN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act.
LobbyistsSHANNON FINLEY · LUKE HATZIS · ANN JABLON · MARTHA KENDRICK · JEFFREY CARROLL · NICK BOUKNIGHT · MICHELLE MATHY · JOHN MARTIN
TargetedSENATE · HOUSE OF REPRESENTATIVES